ANF

Abercrombie & Fitch Reports Record Q3 Sales

Abercrombie & Fitch Co. has reported its third quarter fiscal 2024 results, with record net sales of $1.2 billion, marking a 14% increase from the previous year. The company reported a 16% increase in comparable sales, reflecting broad-based net sales growth across regions and brands. Operating margin expanded by 170 basis points to 14.8%, with operating income increasing by 30% to $179 million.

The company also provided insight into its financial position and liquidity as of November 2, 2024, with cash and equivalents amounting to $683 million, current investments of $56 million, and inventories of $693 million. Abercrombie & Fitch Co. had no long-term gross borrowings, and its liquidity, comprising cash and equivalents and borrowing available under the asset-based revolving credit facility, stood at approximately $1.1 billion.

In terms of cash flow and capital allocation, the company reported net cash provided by operating activities of $403 million, net cash used for investing activities of $187 million, and net cash used for financing activities of $433 million. During the third quarter of 2024, the company repurchased 720,687 shares for approximately $100 million. For the year-to-date period ended November 2, 2024, the company repurchased 924,205 shares for $130 million, with $102 million remaining on the share repurchase authorization established in November 2021.

Looking ahead, Abercrombie & Fitch Co. increased its full-year outlook to net sales growth of 14% to 15% and operating margin around 15%. For the fourth quarter, the company expects net sales in the range of 5% to 7% and operating margin around 16%.

These results reflect the company's continued strong performance and its efforts to achieve sustainable, profitable growth. Following these announcements, the company's shares moved -0.9%, and are now trading at a price of $147.18. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS